Xerostomia Therapeutics Market Growth Drivers, Strategies, Trends, and Forecast by 2031
Coverage: by Product (Salivary Stimulants, Salivary Substitutes, Dentifrices); Type (OTC, Prescription), and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Status : Data Released
- Report Code : TIPRE00004316
- Category : Life Sciences
- No. of Pages : 150
- Available Report Formats :
- Last update date : January 27, 2025
2024 Market Size
US$ 1.59 Bn
Base year value
2031 Forecast
US$ 2.36 Bn
Projected by 2031
CAGR 2025-2031
5.8 %
Growth rate
Addressable Market
US$ 14.03 Bn
(2025-2031)
The Xerostomia Therapeutics Market size is expected to reach US$ 2.36 Billion by 2031. The market is anticipated to register a CAGR of 5.8% during 2025-2031.
The Xerostomia Therapeutics Market report covers analysis by Product (Salivary Stimulants, Salivary Substitutes, Dentifrices); Type (OTC, Prescription), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the Report
The report Xerostomia Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Xerostomia Therapeutics Market Segmentation Product
- Salivary Stimulants
- Salivary Substitutes
- Dentifrices
Type
- OTC
- Prescription
Market Assessment and Insights
- Global market for Xerostomia Therapeutics was valued at US$ 1.59 Billion in 2024
- Annual market size is expected to reach US$ 2.36 Billion by 2031
- Total addressable market (TAM) during 2025-2031 is projected to reach approximately US$ 14.03 Billion
- Market is anticipated to register a CAGR of 5.8% during the forecast period
- The United States represents a key market, supported by Rising Prevalence of Xerostomia, Side Effects of Cancer Treatments, Aging Population, as well as evolving industry dynamics
- Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
- Market opportunities such as Expanding Treatment Options, Collaborations and Partnerships, Increase in Clinical Trials and R&D Investment are expected to influence market dynamics and addressable market
- Report profiles industry participants, including Acacia Pharma, Pfizer, Inc., GlaxoSmithKline plc, Church & Dwight Co., Inc., Lupin, Sun Pharmaceutical Industries, Ltd., Hikma Pharmaceuticals PLC, Pendopharm, OraCoat, Parnell Pharmaceuticals, Inc., while analyzing competitive strategies and innovation developments
-
Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.
● REPORT CUSTOMIZATION
Tailor This Report To Align With Your Specific Business Requirements
This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.
Customize This Report →WHAT YOU CAN ADJUST
- ● Segmentations
- ● Geography
- ● Competitive Analysis
- ● Language Preferences
Xerostomia Therapeutics Market: Strategic Insights
-
Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Xerostomia Therapeutics Market Growth Drivers
- Rising Prevalence of Xerostomia:
The growing incidence of xerostomia, especially among the aging population and cancer patients undergoing treatments like radiation, is driving the demand for effective therapeutics.
- Side Effects of Cancer Treatments:
Chemotherapy and head and neck radiation therapies often lead to dry mouth as a side effect, significantly increasing the need for xerostomia treatment options.
- Aging Population:
As the global elderly population increases, the prevalence of conditions leading to xerostomia, such as SjXerostomia Therapeutics Market Report Scope
By Type- OTC
- Prescription
- UK
- Germany
- France
- Russia
- Italy
- Rest of Europe
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- Brazil
- Argentina
- Rest of South and Central America
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Report Attribute Details Market size in 2024 US$ 1.59 Billion Market Size by 2031 US$ 2.36 Billion Global CAGR (2025 - 2031) 5.8% Historical Data 2021-2023 Forecast period 2025-2031 Segments Covered By Product - Salivary Stimulants
- Salivary Substitutes
- Dentifrices
Regions and Countries Covered North America - US
- Canada
- Mexico
Market leaders and key company profiles - Acacia Pharma
- Pfizer, Inc.
- GlaxoSmithKline plc
- Church & Dwight Co., Inc.
- Lupin
- Sun Pharmaceutical Industries, Ltd.
- Hikma Pharmaceuticals PLC
- Pendopharm
- OraCoat
- Parnell Pharmaceuticals, Inc.
Xerostomia Therapeutics Market Players Density: Understanding Its Impact on Business Dynamics
The Xerostomia Therapeutics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Frequently Asked Questions
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for